Published in Biochem Pharmacol on August 15, 2004
Screening of Potential anti-Trypanosoma cruzi Candidates: In Vitro and In Vivo Studies. Open Med Chem J (2011) 1.22
Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment. Antimicrob Agents Chemother (2010) 1.20
In vitro and in vivo studies of the antiparasitic activity of sterol 14α-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi. Antimicrob Agents Chemother (2013) 1.11
Cellular effects of reversed amidines on Trypanosoma cruzi. Antimicrob Agents Chemother (2007) 1.10
Novel amidines and analogues as promising agents against intracellular parasites: a systematic review. Parasitology (2013) 1.07
In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi. Antimicrob Agents Chemother (2008) 1.03
In vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form--DB1965--against Trypanosoma cruzi infection. PLoS One (2012) 0.99
Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii. Antimicrob Agents Chemother (2008) 0.89
In vitro and in vivo activities of 1,3,4-thiadiazole-2-arylhydrazone derivatives of megazol against Trypanosoma cruzi. Antimicrob Agents Chemother (2010) 0.87
Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo. PLoS One (2011) 0.86
The trypanocidal activity of amidine compounds does not correlate with their binding affinity to Trypanosoma cruzi kinetoplast DNA. Antimicrob Agents Chemother (2011) 0.86
Electrocardiographic findings in acutely and chronically T. cruzi-infected mice treated by a phenyl-substituted analogue of furamidine DB569. Drug Target Insights (2007) 0.81
Biological Efficacy and Toxicity of Diamidines in Myotonic Dystrophy Type 1 Models. J Med Chem (2015) 0.78
Experimental Chemotherapy for Chagas Disease: A Morphological, Biochemical, and Proteomic Overview of Potential Trypanosoma cruzi Targets of Amidines Derivatives and Naphthoquinones. Mol Biol Int (2011) 0.78
In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi. Antimicrob Agents Chemother (2016) 0.78
Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi. Antimicrob Agents Chemother (2016) 0.78
Beta-carboline-3-carboxamide derivatives as promising antileishmanial agents. Ann Trop Med Parasitol (2011) 0.77
Bis-benzimidazole hits against Naegleria fowleri discovered with new high-throughput screens. Antimicrob Agents Chemother (2015) 0.76
Antileishmanial Mechanism of Diamidines: Targeting Kinetoplasts. Antimicrob Agents Chemother (2016) 0.75
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br J Pharmacol (2007) 2.96
The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67
The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes. J Virol (1989) 2.50
Synthesis and antitumor evaluation of some new substituted amidino-benzimidazolyl-furyl-phenyl-acrylates and naphtho[2,1-b]furan-carboxylates. Farmaco (2003) 2.38
Sequence specific thermodynamic and structural properties for DNA.RNA duplexes. Biochemistry (1994) 2.16
Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene (1993) 1.99
Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans. J Med Chem (1977) 1.90
Thermodynamics of DNA duplexes with adjacent G.A mismatches. Biochemistry (1991) 1.90
Evidence for the existence of a pseudoknot structure at the 3' terminus of the flavivirus genomic RNA. Biochemistry (1996) 1.85
Phosphorothioate-modified oligodeoxyribonucleotides. III. NMR and UV spectroscopic studies of the Rp-Rp, Sp-Sp, and Rp-Sp duplexes, [d(GGSAATTCC)]2, derived from diastereomeric O-ethyl phosphorothioates. Nucleic Acids Res (1986) 1.77
Oligonucleotide N3'-->P5' phosphoramidates. Proc Natl Acad Sci U S A (1995) 1.74
DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. Biochemistry (1996) 1.73
Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc Natl Acad Sci U S A (1998) 1.71
Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci U S A (2001) 1.69
The diagnosis and treatment of dentinogenic ghost cell tumor. Int J Oral Maxillofac Surg (2009) 1.67
Human epidermis reconstructed by culture: is it "normal"? J Invest Dermatol (1986) 1.60
Terahertz quantum cascade lasers operating up to ∼ 200 K with optimized oscillator strength and improved injection tunneling. Opt Express (2012) 1.59
NMR and molecular modeling evidence for a G.A mismatch base pair in a purine-rich DNA duplex. Proc Natl Acad Sci U S A (1991) 1.47
Antibacterial effects of endodontic irrigants on black-pigmented gram-negative anaerobes and facultative bacteria. J Endod (1998) 1.45
Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol Cell Biol (1994) 1.45
Duplex stabilities of phosphorothioate, methylphosphonate, and RNA analogs of two DNA 14-mers. Nucleic Acids Res (1991) 1.44
The effect of ionic strength on DNA-ligand unwinding angles for acridine and quinoline derivatives. Nucleic Acids Res (1980) 1.42
Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res (2001) 1.42
DAPI (4',6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sites. Biochemistry (1992) 1.40
Recommendations for the reporting of tissues removed as part of the surgical treatment of cutaneous melanoma. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol (1998) 1.40
Analysis of cooperativity and ion effects in the interaction of quinacrine with DNA. Biopolymers (1979) 1.39
Dicationic diarylfurans as anti-Pneumocystis carinii agents. J Med Chem (1995) 1.38
Collagenous spherulosis mimicking keratinizing squamous metaplasia in a borderline endometrioid tumour of the ovary. Histopathology (1999) 1.38
Effect of current sheets on the solar wind magnetic field power spectrum from the Ulysses observation: from Kraichnan to Kolmogorov scaling. Phys Rev Lett (2011) 1.38
A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. Mol Cell Biol (1993) 1.36
A thermodynamic and structural analysis of DNA minor-groove complex formation. J Mol Biol (2000) 1.35
Mechanism of intercalation: ion effects on the equilibrium and kinetic constants for the interaction of propidium and ethidium with DNA. Biopolymers (1985) 1.35
A crystallographic and spectroscopic study of the complex between d(CGCGAATTCGCG)2 and 2,5-bis(4-guanylphenyl)furan, an analogue of berenil. Structural origins of enhanced DNA-binding affinity. Biochemistry (1996) 1.33
Oligodeoxyribonucleoside methylphosphonates. NMR and UV spectroscopic studies of Rp-Rp and Sp-Sp methylphosphonate (Me) modified duplexes of (d[GGAATTCC])2. Nucleic Acids Res (1987) 1.31
Epidermal morphogenesis and induction of the 67 kD keratin polypeptide by culture of human keratinocytes at the liquid-air interface. Exp Cell Res (1985) 1.31
The role of acetylation in rDNA transcription. Nucleic Acids Res (2001) 1.30
Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol (1996) 1.29
Influence of the dynamic positions of cations on the structure of the DNA minor groove: sequence-dependent effects. J Am Chem Soc (2001) 1.29
Aromatic diamidines as antiparasitic agents. Expert Opin Investig Drugs (2005) 1.29
Interaction specificity of the anthracyclines with deoxyribonucleic acid. Biochemistry (1976) 1.28
Cytotoxic and antitumor potentialities of aporphinoid alkaloids. Curr Med Chem Anticancer Agents (2005) 1.28
Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data. Anal Biochem (2000) 1.28
Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A (1996) 1.28
Nodular fasciitis in the orofacial region. Int J Oral Maxillofac Surg (2006) 1.25
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow. Br J Cancer (1986) 1.25
Diguanidino and "reversed" diamidino 2,5-diarylfurans as antimicrobial agents. J Med Chem (2001) 1.25
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res (1996) 1.21
Retinoic acid improves epidermal morphogenesis. Dev Biol (1989) 1.19
Corynebacterium pseudotuberculosis infection in horses: 538 cases (1982-1993). J Am Vet Med Assoc (1996) 1.18
Specific molecular recognition of mixed nucleic acid sequences: an aromatic dication that binds in the DNA minor groove as a dimer. Proc Natl Acad Sci U S A (2000) 1.18
cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet (1996) 1.17
1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. C R Acad Sci III (2000) 1.16
Stereospecific binding of diastereomeric peptides to salmon sperm DNA. Biochemistry (1976) 1.15
Footprinting studies on ligands which stabilize DNA triplexes: effects on stringency within a parallel triple helix. Biochemistry (1995) 1.15
2,5-bis[4-(N-alkylamidino)phenyl]furans as anti-Pneumocystis carinii agents. J Med Chem (1998) 1.14
Nodal nevi and cutaneous melanomas. Am J Surg Pathol (1996) 1.13
Temporal trends in prevalence of bacteria isolated from foals with sepsis: 1979-2010. Equine Vet J (2013) 1.12
Recognition of ATGA sequences by the unfused aromatic dication DB293 forming stacked dimers in the DNA minor groove. Biochemistry (2001) 1.11
Effect of a triplex-binding ligand on parallel and antiparallel DNA triple helices using short unmodified and acridine-linked oligonucleotides. Biochemistry (1994) 1.11
Phylogeography of Biomphalaria glabrata and B. pfeifferi, important intermediate hosts of Schistosoma mansoni in the New and Old World tropics. Mol Ecol (2003) 1.11
Temporal trends in in vitro antimicrobial susceptibility patterns of bacteria isolated from foals with sepsis: 1979-2010. Equine Vet J (2013) 1.10
The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry (1998) 1.10
Cellular effects of reversed amidines on Trypanosoma cruzi. Antimicrob Agents Chemother (2007) 1.10
Conformation-dependent limited proteolysis of bovine plasma albumin by an enzyme present in commercial albumin preparations. Biochemistry (1971) 1.09
An oligodeoxyribonucleotide N3'--> P5' phosphoramidate duplex forms an A-type helix in solution. Nucleic Acids Res (1996) 1.09
Quinoxaline antibiotics enhance peptide nucleic acid binding to double-stranded DNA. Biochemistry (2000) 1.09
DNA cleavage by hydroxy-salicylidene-ethylendiamine-iron complexes. Nucleic Acids Res (1999) 1.08
Solution structure of a GA mismatch DNA sequence, d(CCATGAATGG)2, determined by 2D NMR and structural refinement methods. Biochemistry (1994) 1.08
Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids. Biochemistry (1985) 1.08
Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol (1992) 1.08
Extended aromatic furan amidino derivatives as anti-Pneumocystis carinii agents. J Med Chem (1998) 1.07
DNA but not topoisomerases is a target for a cytotoxic benzo[5,6]cyclohepta[b]indol-6-one derivative. Anticancer Res (2000) 1.07
Omi/HtrA2 is a positive regulator of autophagy that facilitates the degradation of mutant proteins involved in neurodegenerative diseases. Cell Death Differ (2010) 1.07
Novel amidines and analogues as promising agents against intracellular parasites: a systematic review. Parasitology (2013) 1.07
Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol (2000) 1.07
Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur J Immunol (1999) 1.07
Host and parasite apoptosis following Trypanosoma cruzi infection in in vitro and in vivo models. Cell Tissue Res (2003) 1.06
In vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazoles. Antimicrob Agents Chemother (1998) 1.06
Intercalating drugs: DNA binding and molecular pharmacology. Adv Pharmacol Chemother (1981) 1.05
Poly(dA).poly(dT) exists in an unusual conformation under physiological conditions: propidium binding to poly(dA).poly(dT) and poly[d(A-T)].poly[d(A-T)]. Biochemistry (1985) 1.05
Self-consistent simulations of electroporation dynamics in biological cells subjected to ultrashort electrical pulses. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.05
Alkyl phosphotriester modified oligodeoxyribonucleotides. VI. NMR and UV spectroscopic studies of ethyl phosphotriester (Et) modified Rp-Rp and Sp-Sp duplexes, (d[GGAA(Et)TTCC])2. Nucleic Acids Res (1986) 1.05
Sequence dependent effects in methylphosphonate deoxyribonucleotide double and triple helical complexes. Nucleic Acids Res (1990) 1.05
Abnormal expression of the ATM and TP53 genes in sporadic breast carcinomas. Clin Cancer Res (2000) 1.04
Immunohistochemical expression of WT1 by desmoplastic small round cell tumor: a comparative study with other small round cell tumors. Am J Surg Pathol (2000) 1.04
Relationships between topoisomerase II inhibition, sequence-specificity and DNA binding mode of dicationic diphenylfuran derivatives. Anticancer Drug Des (1999) 1.04